Nuvo Pharmaceuticals Stock Price, News & Analysis
Company Description
Nuvo Pharmaceuticals (OTC: MRVFF) is a publicly traded drug manufacturers—specialty & generic company in the Healthcare sector. The company has a market capitalization of $11.2M.
MRVFF stock has declined 7.6% over the past year.
This page provides a comprehensive overview of MRVFF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Nuvo Pharmaceuticals (MRVFF) stock. Over the past 12 months, the stock has lost 7.6%. At a market capitalization of $11.2M, MRVFF is classified as a micro-cap stock with approximately 11.4M shares outstanding.
Latest News
Nuvo Pharmaceuticals has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 5 with negative movement. Key topics include acquisition, earnings, management, conferences. View all MRVFF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
MRVFF Company Profile & Sector Positioning
Nuvo Pharmaceuticals (MRVFF) operates in the Drug Manufacturers—Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing MRVFF often look at related companies in the same sector, including (CANBD), Vencanna Ventures (TPPRF), Nettec (NXTTF), (GENH), and CHINA INFRASTRUCTURE CONSTRUCTI (CHNC). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate MRVFF's relative position within its industry.